Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard, +15

Nature Biotechnology

Medicinal ChemistryViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitis +7

Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay

Susan F. Radka, Patricia A. Hoist, Michelle Fritsche, +1

Brain Research

Specific ImmunoassayNeurophysiologyMedicineImmunologyNeurochemical Biomarkers +10

Oncostatin M as a Potent Mitogen for AIDS-Kaposi's Sarcoma-Derived Cells

Steven A. Miles, Otoniel Martı́nez-Maza, Ahmad Rezai, +4

Science

ImmunologyImmune RegulationPathologyImmunologic MechanismImmunotherapeutics +17

Purification and Identification of Brain-Derived Neurotrophic Factor from Human Serum

Robert D. Rosenfeld, Luigi Zeni, Nobuyoshi Haniu, +5

Protein Expression and Purification

Neurodegenerative DiseasesBiochemistryNeurophysiologyMedicineNeurochemical Biomarkers +7

Nonrandom association of cellular antigens with HTLV-III virions

James A. Hoxie, Timothy P. Fitzharris, Pierce R. Youngbar, +3

Human Immunology

Molecular VirologyNonrandom AssociationPathogenesisImmunologyVirology +2

A monoclonal antibody directed against the HLA-Bw6 epitope.

Susan F. Radka, Donna D. Kostyu, D. Bernard Amos

The Journal of Immunology

Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism.

Robert I. Grove, Charles E. Mazzucco, Susan F. Radka, +2

Journal of Biological Chemistry

Tyrosine KinaseLipid PeroxidationImmunologyCellular PharmacologyCellular Physiology +21

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

David Weng, P. Masci, Susan F. Radka, +10

Molecular Cancer Therapeutics

Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.

Jie Cai, Parkash S. Gill, R. Masood, +4

PubMed

Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.

Atsushi Hiraiwa, Katsuo Yamanaka, William W. Kwok, +5

Proceedings of the National Academy of Sciences

HistocompatibilityHlaAmino AcidsHla ImmunogeneticsImmunology +18